5-fluorouridine has been researched along with Vitreoretinopathy, Proliferative in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahgat, MM; Bandok, B; el-Aswad, M; Niesman, MR; Peyman, GA; Salah-Eldin, M | 1 |
| Casaroli, R; Corcostegui, B; Fonseca, MJ; García-Arumí, J; Isart, FR; Mateo, C; Pascual, R | 1 |
| Foster, RE; Lewis, H; Schwendeman, SP; Zhou, T | 1 |
3 other study(ies) available for 5-fluorouridine and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Evaluation of toxicity and efficacy of a combination of antineoplastic agents in the prevention of PVR.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cells, Cultured; Disease Models, Animal; Drug Carriers; Drug Evaluation; Fibroblasts; Liposomes; Rabbits; Retina; Retinal Detachment; Retinal Neovascularization; RNA, Ribosomal; Uridine; Vitreoretinopathy, Proliferative | 1994 |
Pharmacokinetics and retinal toxicity of intravitreal liposome-encapsulated 5-fluorouridine.
Topics: Animals; Dose-Response Relationship, Drug; Drug Carriers; Electroretinography; Half-Life; Injections; Liposomes; Rabbits; Reproducibility of Results; Retina; Uridine; Vitreoretinopathy, Proliferative; Vitreous Body | 1997 |
Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy.
Topics: Chromatography, High Pressure Liquid; Drug Implants; Eye; Humans; Microscopy, Electron, Scanning; Molecular Weight; Particle Size; Polymers; Recombinant Proteins; Tissue Plasminogen Activator; Triamcinolone; Uridine; Vitreoretinopathy, Proliferative | 1998 |